2. Academic Validation
  3. Pulmonary pharmacology of WAY-126299A: a dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonist

Pulmonary pharmacology of WAY-126299A: a dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonist

  • Inflamm Res. 1995 Aug:44 Suppl 2:S170-1. doi: 10.1007/BF01778316.
R E Howell 1,  L P Jenkins,  D A Hartman,  W B Gray,  D Kubrak,  R P Carlson,  A F Kreft,  D Grimes
Affiliations

Affiliation

  • 1 Wyeth-Ayerst Research, Princeton, NJ 08543-8000, USA.
PMID: 8548382 DOI: 10.1007/BF01778316
Figures
Products